CATTALINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 7.806
EU - Europa 4.440
AS - Asia 3.831
SA - Sud America 889
Continente sconosciuto - Info sul continente non disponibili 281
AF - Africa 95
OC - Oceania 21
Totale 17.363
Nazione #
US - Stati Uniti d'America 7.568
PL - Polonia 1.611
SG - Singapore 1.350
CN - Cina 995
BR - Brasile 728
IT - Italia 608
HK - Hong Kong 503
FR - Francia 473
UA - Ucraina 470
DE - Germania 388
VN - Vietnam 352
FI - Finlandia 233
GB - Regno Unito 197
RU - Federazione Russa 150
BD - Bangladesh 144
TR - Turchia 139
CA - Canada 109
IE - Irlanda 107
IN - India 93
ID - Indonesia 64
AR - Argentina 53
MX - Messico 39
NL - Olanda 34
EC - Ecuador 33
CO - Colombia 27
IQ - Iraq 27
SE - Svezia 26
ES - Italia 25
ZA - Sudafrica 25
BE - Belgio 24
JP - Giappone 23
LT - Lituania 23
AU - Australia 20
PK - Pakistan 20
AT - Austria 19
JM - Giamaica 17
SA - Arabia Saudita 16
MA - Marocco 14
EG - Egitto 12
HN - Honduras 12
VE - Venezuela 12
PH - Filippine 11
CZ - Repubblica Ceca 10
IL - Israele 10
PE - Perù 10
CR - Costa Rica 9
NI - Nicaragua 9
PY - Paraguay 9
UZ - Uzbekistan 9
DZ - Algeria 8
GT - Guatemala 8
KG - Kirghizistan 8
NG - Nigeria 8
AZ - Azerbaigian 7
CH - Svizzera 7
KE - Kenya 7
MY - Malesia 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
DK - Danimarca 6
IR - Iran 6
JO - Giordania 6
NP - Nepal 6
TN - Tunisia 6
CL - Cile 5
EU - Europa 5
GP - Guadalupe 5
PR - Porto Rico 5
SC - Seychelles 5
SN - Senegal 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
EE - Estonia 4
HU - Ungheria 4
KZ - Kazakistan 4
AL - Albania 3
AM - Armenia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
LB - Libano 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
GR - Grecia 2
KH - Cambogia 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DM - Dominica 1
Totale 17.070
Città #
Warsaw 1.610
Ashburn 740
Singapore 668
Fairfield 628
Woodbridge 515
Hong Kong 501
San Jose 423
Jacksonville 358
Houston 353
The Dalles 280
Council Bluffs 262
Beijing 255
Seattle 244
Cambridge 225
Wilmington 218
Ann Arbor 206
Chandler 186
New York 186
Princeton 166
Helsinki 161
Los Angeles 150
Istanbul 116
Lauterbourg 113
Ho Chi Minh City 109
Dublin 106
Nanjing 88
Santa Clara 88
Columbus 82
Munich 81
São Paulo 73
Dong Ket 70
Milan 70
Brescia 69
Des Moines 66
Chicago 58
Dallas 58
Hanoi 55
Redondo Beach 54
Moscow 49
Phoenix 49
San Francisco 49
Buffalo 45
Shenyang 42
Jakarta 41
North Bergen 40
San Diego 39
Shanghai 39
Nanchang 38
Rome 33
Orem 31
Atlanta 30
Toronto 28
Changsha 26
Dearborn 26
Denver 24
Lancaster 24
Nuremberg 24
Chennai 23
Turku 23
Hebei 22
London 22
Rio de Janeiro 22
Boardman 21
Montreal 21
Tianjin 21
Brussels 20
Frankfurt am Main 20
Jinan 19
Vilnius 19
Brooklyn 18
Lappeenranta 18
Tokyo 18
Romola 15
Assemini 14
Belo Horizonte 14
Charlotte 14
Johannesburg 14
Naples 14
Ningbo 14
Paris 14
Poplar 14
Guangzhou 13
Mexico City 13
Verona 13
Zhengzhou 13
Baghdad 12
Brasília 12
Quito 12
Salt Lake City 12
Stockholm 12
Boston 11
Goiânia 11
Porto Alegre 11
Turin 11
Campinas 10
Dhaka 10
Guayaquil 10
Haiphong 10
Vienna 10
Amsterdam 9
Totale 11.017
Nome #
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry 353
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): An open-label, phase II study 349
Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease 337
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 318
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 316
Developing a Predictive Score for Chronic Arthritis among a Cohort of Children with Musculoskeletal Complaints - The Chronic Arthritis Score Study 301
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 276
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 260
Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: A case series 258
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 254
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 252
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 250
When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children 242
Canakinumab for the treatment of autoinflammatory recurrent fever syndromes 229
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 222
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation. 206
IPSC-DERIVED NEURONS AS AN IN VITRO MODEL FOR THE STUDY OF INTERFERONOPATHIES WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT 205
Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected with Selective IgA Deficiency (SIgAD): a Longitudinal Single-Center Study 200
Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. 189
Body experiences, emotional competence, and psychosocial functioning in juvenile idiopathic arthritis. 186
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 185
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 183
Autosomal recessive agammaglobulinemia: novel insights from mutations in Ig-beta 181
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 178
The change in Ig regulation from children to adults disconnects the correlation with the 3'RR hs1.2 polymorphism 172
DISCRIMINATION AMONG MONOGENIC AND ACQUIRED DISEASE WITH INFLAMMATORY AND AUTOIMMUNE COMPONENT THROUGH THE IN VITRO STUDY OF SIGNAL TRANSDUCERS OF TYPE I INTERFERON 170
Profound T-cell defects in Dubowitz syndrome 167
In silico validation of the autoinflammatory disease damage index 166
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 159
Development of the autoinflammatory disease damage index (ADDI) 154
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry 153
Establishment of three iPSC lines from fibroblasts of a patient with Aicardi Goutières syndrome mutated in RNaseH2B 153
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 152
Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome 151
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 146
Cryopyrin-associated periodic syndromes in Italian Patients: Evaluation of the rate of somatic NLRP3 mosaicism and phenotypic characterization 146
The multifaceted presentation of chronic recurrent multifocal osteomyelitis: A series of 486 cases from the Eurofever international registry 143
Generation of three isogenic induced Pluripotent Stem Cell lines (iPSCs) from fibroblasts of a patient with Aicardi Goutières Syndrome carrying a c.2471G>A dominant mutation in IFIH1 gene 143
Condylar asymmetry in patients with juvenile idiopathic arthritis: Could it be a sign of a possible temporomandibular joints involvement? 142
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 141
Cooperative intervention to assist children with HIV-infection in Burkina Faso: The Brescia experience during the pilot phase of the ESTHER Project. 140
Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients 140
Sex Differences in Pediatric Rheumatology 138
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 137
Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: Analysis by the Pharmachild Safety Adjudication Committee 136
Differentiating PFAPA syndrome from monogenic periodic fevers. 134
Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome 134
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. 132
Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency. 132
Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra 130
Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists’ lens 128
Musculoskeletal pain in children, when hypermobility is the problem 127
Pitfalls of flow cytometric analysis by dihidrorodamyne-123 in the diagnosis of chronic granulomatous disease. 126
Generation of three iPSC lines from fibroblasts of a patient with Aicardi Goutières Syndrome mutated in TREX1 125
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry 124
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. 122
Contraception in adolescents with systemic lupus erythematosus 115
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 114
Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient 113
Overview of fever of unknown origin in adult and paediatric patients 113
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 111
Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry 106
Longitudinal Characterization of Immune Response in a Cohort of Children Hospitalized with Multisystem Inflammatory Syndrome 104
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. 104
Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis 104
Serum amyloid protein A concentration in cryopyrin-associated periodic syndromes patients treated with interleukin-1 beta antagonist 103
Paediatric MAS/HLH caused by a novel monoallelic activating mutation in p110δ 103
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis 100
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 99
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis 99
Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation 99
Musculoskeletal manifestations in hereditary periodic fever syndromes 98
Intervento di Cooperazione sanitaria per l'assistenza ai bambini affetti da HIV/AIDS in Burkina Faso: l'esperienza della Clinica Pediatrica di Brescia. 97
Favourable and sustained response to anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis. 97
Pathogenesis of Autoimmune Cytopenias in Inborn Errors of Immunity Revealing Novel Therapeutic Targets 97
Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection. 96
Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome 96
Prevalence of cranial involvement in a cohort of Italian patients with chronic non-bacterial osteomyelitis 96
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network 95
Prevention of Flare Recurrences in Childhood-Refractory Chronic Uveitis: An Open-LabelComparative Study of Adalimumab Versus Infliximab 95
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 94
Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome 94
Pitfalls of flow cytometric analysis by dihydrorodamine-123 in the diagnosis of chronic granulomatous disease 93
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 92
The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C) 91
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severity 91
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 91
iPSC-derived 3d brain organoids cultured in a bioreactor as an in vitro model for the study of microcephaly in Aicardi Goutières syndrome. 88
Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics 88
OBSIDIAN - real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis 88
Treatment response to Janus kinase inhibitor in a child affected by Aicardi-Goutières syndrome 88
The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C 87
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial 87
Covid-19 and autoimmunity 86
Inflammatory pathways signal transducers analysis in iPSC-derived neurons and 3D cerebral organoids 85
Efficacy and Safety of Adalimumab in Pediatric Non-infectious Non-anterior Uveitis: Real-life Experience From the International AIDA Network Uveitis Registry 84
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry 84
Cardiac MRI in midterm follow-up of MISC: a multicenter study 82
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 82
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 81
Totale 14.703
Categoria #
all - tutte 82.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022531 0 0 0 55 6 39 29 59 35 86 56 166
2022/2023609 91 6 8 59 50 175 11 53 91 7 29 29
2023/2024867 53 20 92 65 25 150 30 37 250 8 17 120
2024/20252.325 11 28 31 358 241 161 214 106 298 186 385 306
2025/20264.830 416 589 377 730 402 306 634 163 296 426 288 203
2026/20271.887 234 261 532 860 0 0 0 0 0 0 0 0
Totale 17.363